Skip to main content

Table 2 Weighted and unweighted estimation of the prevalence of multimorbidity and fourteen NCDs by urban vs. rural areas in 2011

From: Neighborhood’s locality, road types, and residents’ multimorbidity: evidence from China’s middle-aged and older adults

Characteristics

Unweighted sample, n (%)

Weighted to reflect to China’s population, % (95 CI)

All (N = 13,413)

Urban (N = 5639)

Rural (N = 7774)

All

Urban

Rural

Chronic disease

 0

4216 (31.43)

1730 (30.68)

2486 (31.98)

32.09

(28.97–34.11)

32.61

(30.62–34.67)

31.48

(30.50–33.72)

 1

4020 (29.97)

1665 (29.53)

2355 (30.29)

30.58

(28.73–32.57)

30.55

(29.25–31.89)

30.62

(29.46–31.73)

 2

2648 (19.74)

1146 (20.32)

1502 (19.32)

19.11

(17.89–21.28)

18.75

(17.65–19.90)

19.53

(18.14–20.12)

 3

1393 (10.39)

586 (10.39)

807 (10.38)

9.81

(8.58–10.62)

10.04

(9.19–10.95)

9.55

(9.16–10.50)

 4

680 (5.07)

310 (5.5)

370 (4.76)

4.82

(4.17–6.07)

4.64

(4.08–5.28)

5.04

(4.31–5.39)

 5

304 (2.27)

131 (2.32)

173 (2.23)

2.25

(1.61–2.72)

2.39

(1.95–2.92)

2.10

(1.92–2.65)

 6

97 (0.72)

46 (0.82)

51 (0.66)

0.93

(0.69–2.25)

0.65

(0.47–0.91)

1.25

(0.62–1.38)

 7

37 (0.28)

17 (0.3)

20 (0.26)

0.27

(0.17–0.54)

0.24

(0.14–0.42)

0.31

(0.18–0.40)

 8

12 (0.09)

5 (0.09)

7 (0.09)

0.09

(0.03–0.21)

0.09

(0.04–0.22)

0.08

(0.05–0.16)

 9

4 (0.03)

2 (0.04)

2 (0.03)

0.03

(0.01–0.12)

0.03

(0.01–0.12)

0.03

(0.01–0.08)

 10

2 (0.01)

1 (0.02)

1 (0.01)

0.02

(0.00–0.16)

0.01

(0.00–0.08)

0.02

(0.00–0.07)

arthritis or rheumatism

4570 (34.07)

1923 (34.1)

2647 (34.05)

33.08

(31.29–34.93)

32.87

(30.59–35.24)

33.33

(30.53–36.25)

hypertension

3276 (24.42)

1453 (25.77)

1823 (23.45)

24.54

(22.85–26.31)

23.69

(21.91–25.58)

25.53

(22.55–28.75)

digestive disease

3083 (22.99)

1251 (22.18)

1832 (23.57)

21.98

(20.68–23.33)

22.69

(21.24–24.21)

21.15

(18.92–23.56)

heart problems

1538 (11.47)

728 (12.91)

810 (10.42)

11.21

(10.23–12.27)

10.18

(9.05–11.45)

12.41

(10.79–14.23)

chronic lung diseases

1616 (12.05)

688 (12.2)

928 (11.94)

11.82

(10.99–12.71)

11.89

(10.84–13.03)

11.74

(10.45–13.18)

dyslipidemia

1162 (8.66)

535 (9.49)

627 (8.07)

8.86

(7.99–9.81)

8.21

(7.12–9.45)

9.62

(8.28–11.14)

chronic kidney disease

833 (6.21)

324 (5.75)

509 (6.55)

5.96

(5.34–6.64)

6.48

(5.58–7.52)

5.35

(4.57–6.25)

diabetes

743 (5.54)

356 (6.31)

387 (4.98)

5.85

(5.24–6.52)

5.14

(4.45–5.93)

6.67

(5.67–7.83)

Chronic liver disease

521 (3.88)

224 (3.97)

297 (3.82)

3.90

(3.44–4.43)

3.79

(3.23–4.45)

4.03

(3.32–4.90)

asthma

511 (3.81)

206 (3.65)

305 (3.92)

3.69

(3.26–4.17)

3.97

(3.41–4.62)

3.36

(2.75–4.11)

stroke

407 (3.03)

197 (3.49)

210 (2.7)

2.17

(1.83–2.57)

2.00

(1.58–2.52)

2.37

(1.84–3.03)

mental problems

258 (1.92)

111 (1.97)

147 (1.89)

1.78

(1.48–2.14)

1.79

(1.40–2.28)

1.77

(1.34–2.34)

memory-related disease

177 (1.32)

84 (1.49)

93 (1.2)

1.45

(1.16–1.80)

1.43

(1.08–1.89)

1.47

(1.03–2.08)

cancer

132 (0.98)

51 (0.9)

81 (1.04)

0.90

(0.74–1.09)

1.03

(0.82–1.30)

0.74

(0.52–1.04)

  1. Note: CI confident interval